In Brief: Possis Medical
This article was originally published in The Gray Sheet
Possis Medical: Plans to respond within 45 days to "a series of questions" raised by FDA about its pending 510(k) application for the AngioJet rapid thrombectomy system for peripheral applications, the firm states in a June 20 release. The application was filed earlier this year ("The Gray Sheet" March 18, In Brief). The Minneapolis firm "believes its answers will support a favorable decision by the FDA"...
You may also be interested in...
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.